Abstract
Periprosthetic joint infections of the shoulder (PJIS) are the major cause for revision within the first two post-operative years, and are challenging both to diagnose and treat. Success depends on early identification of microorganisms, appropriate surgical procedures and efficient antibiotic administration. The peculiar microbiology of the shoulder may render the criteria for hip/knee PJI management inappropriate. In addition, later cases with clinically subtle signs often present diagnostic challenges. In recent years, specific issues of PJIS have been managed through the use of new instruments, such as MicroDTTect in pathogen detection and Bioactive Glass and tantalum cones in humeral bone loss. In the literature to date, no reports have been found that discuss the application in shoulder revisions and infections. The early identification of the microorganisms that cause infection may help improve both treatment strategies and the efficacy of therapy. MicroDTTect proved to be more efficient than swab collection for bacterial identification in orthopedic surgery, thus reducing analysis costs. The increasing number of shoulder arthroplasties is associated with an increase in the number of revisions. In cases of massive metaphyseal humeral bone loss, several techniques have been described; no reports have been reported regarding tantalum in humeral bone loss management. In some cases the tantalum cones required adaptation for femoral diaphysis in the augmentation of the humerus metaphysis and bone loss management improvement. Obtaining stable osseointegration of prosthetic implants is one of the greatest issues in orthopedic surgery, and even more crucial in revisions. Bioactive glasses demonstrated good regenerative and osseointegration properties, and an excellent candidate as a bone graft, scaffold and antibiotics deliverer. The Bioactive glasses were used to increase prosthesis-bone interface stability and fill bone defects in PJIS revision surgeries, contributing to the prevention of re-infection. Longer-term follow-up will be necessary to determine if construction durability is improved in the long term.
Highlights
Periprosthetic joint infection of the shoulder (PJIS) is a rare but serious complication that is challenging to treat
The mean incidence of PJIS is reported as 1.1% [1], and reverse arthroplasty (RSA) infection rate 3.8% [2,3]
In chronic infections in less serious cases or in patients who are ineligible for revision, surgical debridement with implant removal, antibiotic spacer placement, or simple resection arthroplasty would be the treatment of choice
Summary
Periprosthetic joint infection of the shoulder (PJIS) is a rare but serious complication that is challenging to treat. Treatment options for PJIS include intravenous antibiotics, tissue debridement with retention of the prosthesis, resection arthroplasty, one-stage and two-stage exchange procedures, arthrodesis, and amputation. Treatment strategy depends on infection timing: within 30 days after surgery, a surgical debridement with polyethylene exchange (and glenosphere in RSA) may be appropriate [14]. In cases of hematogenous infection 30 days or more after surgery, implant removal with tissues debridement, one-stage or two-stage procedure (followed by species-directed antibiotic administration), should be considered [10,14,15]. In chronic infections in less serious cases or in patients who are ineligible for revision, surgical debridement with implant removal, antibiotic spacer placement, or simple resection arthroplasty would be the treatment of choice. The aim of the present study was to review new opportunities in shoulder periprosthetic infections, focusing on the use of MicroDTTect in pathogen detection, Bioactive Glass, and tantalum cones in humeral bone loss, and to report on our experience of utilizing them
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.